Stroke as the first and recurrent manifestation of takayasu arteritis: a case report

来源 :2013中国心脏大会(CHC) | 被引量 : 0次 | 上传用户:Spring_880916
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Takayasu arteritis is a chronic, idiopathic disease characterized by granulomatous vasculitis of medium and large arteries.In addition to constitutional symptoms, it causes various clinical morbidities, such as arm claudication, decreased arterial pulses, carotidynia and hypertension.
其他文献
Fructose is widely used as a sweetener in production of many foods, yet the relation between fiuctose intake and cholesterol remains uncertain.We performed a systematic review and meta-analysis of hum
会议
Introduction Several studies have demonstrated an inverse relationship between systolic blood pressure at admission and mortality in patients presenting with acute myocardial infarction (AMI).However,
会议
Objective The aim of the present study was to evaluate the safety, feasibility, procedural variables and long-term outcome by transradial (TR)approach compared with the tranfemoral (TF) acess in tripl
会议
Objectove Erythropoietin (Epo) plays a crucial role in the formation and maturation of erythroeytes and is produced primarily by peritubular cells in the renal cortex.Previous studies suggest that ren
会议
Background Though drug-eluting stent (DES) almost solved problem of restenosis, safety issues related to stent thrombosis are still the major concem of DES.We hypothesized that hybrid stent implantati
会议
Objective Reviewthe patient data that underwent surgical procedures which after interventional failure or occurred serious complications.Su mmarize open heart surgical Methods, especially rare complic
会议
Background Transradial coronary intervention is a safe and effective method of percutaneous revascularization.Furthermore, the indications for transradial percutaneous coronary intervention (PCI) are
会议
Background Treatment of drug-eluting stent (DES) restenosis is still challenging with no established best strategy.The PEPCAD China ISR trial was to demonstrate the efficacy and safety of paclitaxelco
会议
Background Digoxin is frequently used for rate control in paroxysmal, persistent and permanent atrial fibrillation (AF).The relationship of digoxin and mortality was so different in recent studies, an
会议
Objective To compare the clinical characteristics, treatment Methods and outcomes in Chinese non ST elevated acute coronary syndromes (NSTE-ACS) patients from two large clinical trials in different ti
会议